Mitoxantrone trial in multiple sclerosis

被引：4

作者：

Chaudhuri, A ^{[1
]}

Behan, PO ^{[1
]}

机构：

[1] Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland

来源：

LANCET | 2003年 / 361卷 / 9363期

关键词：

D O I：

10.1016/S0140-6736(03)12875-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1133 / 1134

页数：2

共 5 条

[1]

BEHAN PO, 2002, J R COLL PHYS EDINB, V32, P244

[2] Relapses and progression of disability in multiple sclerosis. [J].

Confavreux, C ;

Vukusic, S ;

Moreau, T ;

Adeleine, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20) :1430-1438

[3] Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis [J].

Filippi, M ;

Bozzali, M ;

Rovaris, M ;

Gonen, O ;

Kesavadas, C ;

Ghezzi, A ;

Martinelli, V ;

Grossman, RI ;

Scotti, G ;

Comi, G ;

Falini, A .

BRAIN, 2003, 126 :433-437

[4] Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial [J].

Hartung, HP ;

Gonsette, R ;

König, N ;

Kwiecinski, H ;

Guseo, A ;

Morrissey, SP ;

Krapf, H ;

Zwingers, T .

LANCET, 2002, 360 (9350) :2018-2025

[5] Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis [J].

Narayana, PA ;

Doyle, TJ ;

Lai, DJ ;

Wolinsky, JS .

ANNALS OF NEUROLOGY, 1998, 43 (01) :56-71

← 1 →